Fabio Blandini

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Oxidopamine 37%
3. Basal Ganglia 21%
4. Rodentia 20%
5. Subthalamic Nucleus 15%
6. Dopamine Agonists 14%
7. Corpus Striatum 14%
8. Glucosylceramidase 14%
9. Neuroprotective Agents 14%
10. Nitroglycerin 13%
11. Migraine Disorders 13%
12. Brain 12%
13. Animal Models 11%
14. Dopamine 10%
15. Synucleins 10%
16. Injections 9%
17. Blood Platelets 9%
18. Pars Compacta 9%
19. Neuroprotection 9%
20. Levodopa 9%
21. Therapeutics 8%
22. Dopaminergic Neurons 8%
23. Lymphocytes 8%
24. Catecholamines 8%
25. Parkinsonian Disorders 8%
26. Pars Reticulata 8%
27. Dyskinesias 7%
28. Substantia Nigra 7%
29. 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine 7%
30. Quinpirole 7%
31. Mesenchymal Stem Cells 7%
32. Apoptosis 7%
33. Alzheimer Disease 6%
34. Glutamic Acid 6%
35. Neurotoxins 6%
36. Proteins 6%
37. Dihydroxyphenylalanine 6%
38. Mutation 6%
39. Oxidative Stress 6%
40. Neuronal Plasticity 6%
41. Caspase 3 6%
42. Animals 6%
43. Neuroblastoma 6%
44. Neurodegenerative Diseases 6%
45. Apomorphine 6%
46. Norepinephrine 5%
47. Neurons 5%
48. Hippocampus 5%
49. Synucleinopathies 5%
50. Dopamine Receptors 5%